Print Page  Close Window
Meridian Bioscience to Present at the InvesTristate Regional Public Company Investment Conference

CINCINNATI--(BUSINESS WIRE)--June 15, 2006--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced that the Company has been invited to present at the InvesTristate Regional Public Company Investment Conference on Tuesday, June 20, 2006 at 10:55 a.m. ET at the Hyatt Regency, Cincinnati, Ohio. Jack Kraeutler, President and Chief Operating Officer and Melissa Lueke, Vice President and Chief Financial Officer, are scheduled to present. A question and answer session will follow and some of the information provided during the session may not have been previously disclosed.

Meridian invites investors to listen to management's remarks, over the Internet, on the Company's website at The link to the Conference is on the Investor Relations home page.

Meridian is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral, and respiratory infections. Meridian diagnostic products are used outside of the human body and require little or no special equipment. The Company's products are designed to enhance patient well-being while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal and upper respiratory infections, serology, parasitology and fungal disease diagnosis. In addition, Meridian is a supplier of rare reagents and specialty biologicals along with proteins and other biologicals used by biopharmaceutical companies engaged in research for new drugs and vaccines. The Company markets its products to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices and diagnostics manufacturers in more than 60 countries around the world. The Company's shares are traded through Nasdaq's National Market, symbol VIVO. Meridian's website address is

CONTACT: Meridian Bioscience, Inc.
John A. Kraeutler or Melissa Lueke, 513-271-3700

SOURCE: Meridian Bioscience, Inc.